SEQIRUS INC NC

Total Awards
25
contract actions
Lifetime Value
$5.9B
total obligated
Active Since
2026
first contract
NAICS Codes
1
industry categories
Agencies
1
customers
You're viewing a free preview. Upgrade to Basic ($9/mo) to see full award descriptions, contact info, and CSV export. See Plans →

Top NAICS Categories

25 awards
$5,881.0M

Top Customer Agencies

Department of Health and Human Services
31 awards
$5,968.2M

Recent Awards (last 15)

(No description)
Department of Health and Human Services · NC
$10,961
Oct 22, 2026
GSK STORAGE AND STABILITY TESTING FOR H5N1 A INDO BULK VACCINE
Department of Health and Human Services · NC
$2,225,250
Oct 22, 2026
IGF::OT::IGF FOR OTHER FUNCTIONS AMCG ADMINISTRATIVE STAFFING SUPPORT
Department of Health and Human Services · NC
$1,270,603
Oct 22, 2026
IGF::OT::IGF FOR OTHER FUNCTIONS COO ADMINISTRATIVE STAFFING SUPPORT
Department of Health and Human Services · NC
$3,542,802
Oct 22, 2026
ASPR-18-00579
Department of Health and Human Services · NC
$10,961
Oct 22, 2026
GSK STORAGE AND STABILITY TESTING FOR H5N1 A INDO BULK VACCINE
Department of Health and Human Services · NC
$2,225,250
Oct 22, 2026
IGF::OT::IGF FOR OTHER FUNCTIONS AMCG ADMINISTRATIVE STAFFING SUPPORT
Department of Health and Human Services · NC
$1,270,603
Oct 22, 2026
IGF::OT::IGF FOR OTHER FUNCTIONS COO ADMINISTRATIVE STAFFING SUPPORT
Department of Health and Human Services · NC
$3,542,802
Oct 22, 2026
FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION
Department of Health and Human Services · NC
$42,769,479
Sep 29, 2026
FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION
Department of Health and Human Services · NC
$42,769,479
Sep 29, 2026
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO CONFIRM IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PRO…
Department of Health and Human Services · NC
$450,052
Sep 24, 2026
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
Department of Health and Human Services · NC
$2,148,912
Sep 24, 2026
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO CONFIRM IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PRO…
Department of Health and Human Services · NC
$450,052
Sep 24, 2026
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
Department of Health and Human Services · NC
$2,148,912
Sep 24, 2026
TAS::75 0140::TAS CONSTRUCTION OF VACCINE MANUFACTURING FACILITY
Department of Health and Human Services · NC
$1,430,622,665
Jul 14, 2026